EUVIMEDOpdag EUVIMED
Crossref

Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia

E Stikeman, D Bianco

Journal of Small Animal Practice · 2024

DOI: 10.1111/jsap.13700 ↗

At a glance

Journal article in Journal of Small Animal Practice, 2024. Written by E Stikeman and 1 co-authors. Institution: Internal Medicine Department, Metropolitan Animal Specialty Hospital, 6565 Santa Monica Boulevard, Los Angeles, CA, 90038, USA. Major MEDLINE topics: Dog Diseases, Immunoglobulins, Intravenous, Neoplasms. Cited 1 times so far (Crossref); 62 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objectives To evaluate the safety and efficacy of human intravenous immunoglobulin in dogs with newly diagnosed malignancy and presumed secondary immune‐mediated thrombocytopenia. Materials and Methods Twelve client‐owned dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia were prospectively enrolled to receive a single infusion of human intravenous immunoglobulin at a dose of 0.5 to 1 mg/kg intravenous over 8 hours. A complete treatment response was defined as a platelet estimation of ≥40,000 platelets/μL within 24 hours and a partial response within 48 hours from the completion of human intravenous immunoglobulin infusion. No treatment response was defined as a platelet estimation remaining

Subjects

MeSH terms (MEDLINE)

Dog DiseasesImmunoglobulins, IntravenousNeoplasmsDogsAnimalsMaleFemalePilot ProjectsProspective StudiesHumansPurpura, Thrombocytopenic, IdiopathicTreatment OutcomeThrombocytopenia

Substances

Immunoglobulins, Intravenous

Authors and institutions

  • Internal Medicine Department, Metropolitan Animal Specialty Hospital, 6565 Santa Monica Boulevard, Los Angeles, CA, 90038, USA.

Cite

APA

Stikeman, E., & Bianco, D. (2024). Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia. Journal of Small Animal Practice. https://doi.org/10.1111/jsap.13700

Vancouver

Stikeman E, Bianco D. Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia. Journal of Small Animal Practice. 2024. doi:10.1111/jsap.13700

BibTeX
@article{Stikeman2024,
  author = {Stikeman, E and Bianco, D},
  title = {Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia},
  journal = {Journal of Small Animal Practice},
  year = {2024},
  doi = {10.1111/jsap.13700}
}
Start for free →